Nuvera Ready to Launch Tests for Endocrine Therapy, Chemotherapy Response in Breast Cancer | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Following the results of a study suggesting that its genomic test may have use in predicting chemotherapy response in patients with breast cancer, Nuvera Biosciences said that a launch of the test, as well as another for predicting endocrine therapy response, is in the works.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.